bioRxivMicrobiology
Structure-based design of stabilized recombinant influenza neuraminidase tetramers
D. Ellis, J. Lederhofer, O. J. Acton, Y. Tsybovsky, S. Kephart, C. Yap, R. A. Gillespie, A. Creanga, T. Stephens, D. Pettie, M. Murphy, A. J. Borst, Y.-J. Park, K. K. Lee, B. S. Graham, D. Veesler, N. P. King, M. Kanekiyo
Abstract
Influenza virus neuraminidase (NA) is a major antiviral drug target and has recently reemerged as a key target of antibody-mediated protective immunity. Here we show that recombinant NAs across all non-bat subtypes adopt various tetrameric conformations, including a previously unreported "open" state that may help explain poorly understood variations in NA stability across viral strains and subtypes. We used homology-directed protein design to uncover the structural principles underlying these distinct tetrameric conformations and stabilize multiple recombinant NAs in the "closed" state. In addition to improving thermal stability, conformational stabilization improved affinity to protective antibodies elicited by viral infection, including antibodies targeting a quaternary epitope and the broadly conserved catalytic site. The stabilized NA proteins can also be integrated into viruses without affecting fitness. Our findings provide a deeper understanding of NA structure, stability, and antigenicity, as well as a roadmap towards structure-based discovery of NA-directed therapeutics and vaccines.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Design of the recombinant influenza neuraminidase antigen is crucial for protective efficacy
- Structure-Guided Loop Grafting Improves Expression and Stability of Influenza Neuraminidase for Vaccine Development
Pramila Rijal, Leiyan Wei, … Alain Townsend·bioRxiv·Oct 11, 2024
- A rationally designed neuraminidase immunogen elicits humoral responses to a conserved viral site
Rachel Hecht, Faez Amokrane Nait Mohamed, … Aaron G. Schmidt·bioRxiv·Aug 17, 2026
- Modernizing the original influenza vaccine to enhance protective antibody responses against neuraminidase antigens
M. Rakic-Martinez, J. Gao, … R. Daniels·bioRxiv·Feb 20, 2023
- Structural Convergence and Water-Mediated Substrate Mimicry Enable Broad Neuraminidase Inhibition by Human Antibodies
Julia Lederhofer, Andrew J. Borst, … Masaru Kanekiyo·Nature CommunicationsPeer-reviewed·Aug 1, 2025
- Structural basis of broad protection against influenza virus by a human antibody targeting the neuraminidase active site via a recurring motif in CDR H3
Gyunghee Jo, Seiya Yamayoshi, … Andrew B. Ward·Nature CommunicationsPeer-reviewed·Aug 1, 2025